16-3850636-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_004380.3(CREBBP):​c.459G>A​(p.Pro153Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,614,200 control chromosomes in the GnomAD database, including 179 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P153P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0096 ( 20 hom., cov: 31)
Exomes 𝑓: 0.012 ( 159 hom. )

Consequence

CREBBP
NM_004380.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.658

Publications

5 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 16-3850636-C-T is Benign according to our data. Variant chr16-3850636-C-T is described in ClinVar as Benign. ClinVar VariationId is 95049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.658 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00958 (1459/152334) while in subpopulation NFE AF = 0.0118 (805/68034). AF 95% confidence interval is 0.0112. There are 20 homozygotes in GnomAd4. There are 777 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1459 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.459G>Ap.Pro153Pro
synonymous
Exon 2 of 31NP_004371.2
CREBBP
NM_001079846.1
c.459G>Ap.Pro153Pro
synonymous
Exon 2 of 30NP_001073315.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.459G>Ap.Pro153Pro
synonymous
Exon 2 of 31ENSP00000262367.5
CREBBP
ENST00000382070.7
TSL:1
c.459G>Ap.Pro153Pro
synonymous
Exon 2 of 30ENSP00000371502.3

Frequencies

GnomAD3 genomes
AF:
0.00959
AC:
1460
AN:
152216
Hom.:
20
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00524
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0436
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.0107
AC:
2693
AN:
250982
AF XY:
0.0106
show subpopulations
Gnomad AFR exome
AF:
0.00187
Gnomad AMR exome
AF:
0.00523
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0426
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.0136
GnomAD4 exome
AF:
0.0119
AC:
17447
AN:
1461866
Hom.:
159
Cov.:
32
AF XY:
0.0117
AC XY:
8479
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00182
AC:
61
AN:
33480
American (AMR)
AF:
0.00521
AC:
233
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00471
AC:
123
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00551
AC:
475
AN:
86258
European-Finnish (FIN)
AF:
0.0450
AC:
2401
AN:
53394
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.0121
AC:
13476
AN:
1112010
Other (OTH)
AF:
0.0108
AC:
652
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1251
2501
3752
5002
6253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00958
AC:
1459
AN:
152334
Hom.:
20
Cov.:
31
AF XY:
0.0104
AC XY:
777
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41574
American (AMR)
AF:
0.00523
AC:
80
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4828
European-Finnish (FIN)
AF:
0.0436
AC:
463
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0118
AC:
805
AN:
68034
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
82
164
245
327
409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00881
Hom.:
8
Bravo
AF:
0.00649
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0110
EpiControl
AF:
0.0112

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
6.8
DANN
Benign
0.57
PhyloP100
-0.66
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56388626; hg19: chr16-3900637; COSMIC: COSV99268426; COSMIC: COSV99268426; API